Author

I. de Heer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:DNA methylation· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

M. Sanson· 3 shared T. Gorlia· 3 shared V. Golfinopoulos· 3 shared W. Wick· 3 shared Y. Hoogstrate· 3 shared C. M. S. Tesileanu· 2 shared E. Franceschi· 2 shared J. M. Kros· 2 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. Sanson

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma

S. A. Ghisai, L. van Hijfte, W. R. Vallentgoed, C. M. S. Tesileanu, I. de Heer, J. M. Kros, M. Sanson, T. Gorlia, W. Wick, M. A. Vogelbaum, A. A. Brandes, E. Franceschi, P. M. Clement, A. K. Nowak, V. Golfinopoulos, , Y. Hoogstrate

This study identifies DNA-methylation and RNA-expression signatures that improve grading of IDH-mutant astrocytomas beyond current methods.

bioRxiv · Mar 19, 2024Cancer Biology

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

W. R. Vallentgoed, Y. Hoogstrate, K. A. van Garderen, L. van Hijfte, E. van Dijk, M. C. Kouwenhoven, J. M. Niers, K. Draaisma, I. Martin, W. W. de Leng, C. M. S. Tesileanu, I. de Heer, M. Diepeveen, A. Lavrova, P. P. Eijk, , P. J. French

The paper analyzes multi-omics data from IDH-mutant astrocytomas to identify molecular markers of malignant progression linked to cell cycling and DNA methylation changes.

bioRxiv · Mar 5, 2024Cancer Biology

DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomas

M. Tesileanu, W. Vallentgoed, M. Sanson, W. Taal, P. Clement, W. Wick, A. Brandes, J.-F. Baurain, O. Chinot, H. Wheeler, S. Gill, M. Griffin, L. Rogers, R. Ruda, M. Weller, , van den Bent

The paper shows that IDH mutations other than p.R132H in 1p/19q non-codeleted astrocytomas are linked to higher DNA methylation and better patient survival.

bioRxiv · Dec 10, 2020 · PreprintCancer Biology

Effective Tyrosine Kinase Inhibitors result in the intracellular accumulation of EGFR and allows response prediction in patients

M. de Wit, Y. Gao, D. Mercieca, I. de Heer, B. Valkenburg, M. van Royen, J. Aerts, P. Sillevis Smitt, P. French

The paper shows that EGFR tyrosine kinase inhibitors (TKIs) cause intracellular EGFR accumulation only in specific mutation-TKI combinations, which predicts clinical response in patients.

bioRxiv · Oct 21, 2019 · PreprintCancer Biology